Literature DB >> 22071694

Cyclin B1 interacts with the BH3-only protein Bim and mediates its phosphorylation by Cdk1 during mitosis.

Seán Mac Fhearraigh1, Margaret M Mc Gee.   

Abstract

Protracted mitotic arrest leads to cell death; however, the molecular signals that link these distinct processes remain poorly understood. Here we report that the pro-apoptotic BH3-only family member Bim undergoes phosphorylation in K562 cells following treatment with the microtubule targeting agents Taxol and Nocodazole. The phosphorylation of two Bim isoforms, BimEL and BimL, at the mitochondria correlates with mitotic arrest and precedes cell death induced by Taxol. It was also found that Bim undergoes transient phosphorylation during normal mitosis in K562 cells. In addition, siRNA silencing of Bim reduces sensitivity to Taxol-induced cell death. The transition of K562 cells from mitosis to G1 results in the loss of BimEL and BimL phosphorylation and correlates with the degradation of cyclin B1. The Cdk1 inhibitors, RO-3306 and Purvalanol A, block Bim phosphorylation in mitotically arrested cells. Importantly, it was found that cyclin B1 co-immunoprecipitates with endogenous Bim in mitotic extracts. Furthermore, active recombinant Cdk1/cyclin B1 phosphorylates BimEL and BimL in vitro and Serine 44 on BimL has been identified as a Cdk1 phosphorylation site. Collectively, these results suggest that Cdk1/cyclin B1-dependent hyper-phosphorylation of Bim during prolonged mitotic arrest is an important cell death signal.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22071694     DOI: 10.4161/cc.10.22.18020

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  15 in total

1.  Bim vanishes in the light of a mitotic Aurora.

Authors:  L L Fava; M D Haschka; A Villunger
Journal:  Cell Death Differ       Date:  2013-12       Impact factor: 15.828

2.  The end of mitosis from a phosphatase perspective.

Authors:  Roberta Visconti; Luca Palazzo; Anna Pepe; Rose Della Monica; Domenico Grieco
Journal:  Cell Cycle       Date:  2013-01-01       Impact factor: 4.534

3.  Sequential Cdk1 and Plk1 phosphorylation of caspase-8 triggers apoptotic cell death during mitosis.

Authors:  Yves Matthess; Monika Raab; Rainald Knecht; Sven Becker; Klaus Strebhardt
Journal:  Mol Oncol       Date:  2014-01-17       Impact factor: 6.603

Review 4.  Regulation of Bim in Health and Disease.

Authors:  Ronit Vogt Sionov; Spiros A Vlahopoulos; Zvi Granot
Journal:  Oncotarget       Date:  2015-09-15

5.  BimEL is phosphorylated at mitosis by Aurora A and targeted for degradation by βTrCP1.

Authors:  M Moustafa-Kamal; I Gamache; Y Lu; S Li; J G Teodoro
Journal:  Cell Death Differ       Date:  2013-08-02       Impact factor: 15.828

6.  Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicity.

Authors:  W Kudo; H-P Lee; M A Smith; X Zhu; S Matsuyama; H-G Lee
Journal:  Cell Death Dis       Date:  2012-05-17       Impact factor: 8.469

7.  The NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrest.

Authors:  Manuel D Haschka; Claudia Soratroi; Susanne Kirschnek; Georg Häcker; Richard Hilbe; Stephan Geley; Andreas Villunger; Luca L Fava
Journal:  Nat Commun       Date:  2015-04-29       Impact factor: 14.919

8.  Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme.

Authors:  Xiaohui Yu; Lifang Yang; Murray J Cairns; Crispin Dass; Edward Saravolac; Xiong Li; Lun-Quan Sun
Journal:  Oncotarget       Date:  2014-10-15

9.  Sequential Cdk1 and Plk1 phosphorylation of protein tyrosine phosphatase 1B promotes mitotic cell death.

Authors:  D S O'Donovan; S MacFhearraigh; J Whitfield; L B Swigart; G I Evan; M M Mc Gee
Journal:  Cell Death Dis       Date:  2013-01-24       Impact factor: 8.469

10.  Protect and serve: Bcl-2 proteins as guardians and rulers of cancer cell survival.

Authors:  Frédérique Braun; Sophie de Carné Trécesson; Joséphine Bertin-Ciftci; Philippe Juin
Journal:  Cell Cycle       Date:  2013-08-13       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.